Parkinson Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Together, these findings provide strong evidence for GAK clathrin-binding- and J-domain transcripts' influence on PD pathogenicity, and for a role for GAK in regulating synaptic function in PD.
|
27508417 |
2016 |
Parkinson Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Cyclin-G-associated kinase (GAK), a PD susceptibility gene identified through genome-wide association studies (GWAS), is a ubiquitous serine/threonine kinase involved in clathrin uncoating, though its PD-related function remains elusive.
|
28147270 |
2017 |
Hepatitis C
|
0.040 |
Biomarker
|
disease |
BEFREE |
We previously reported that AAK1 and GAK, kinase regulators of the host adaptor proteins AP1 and AP2, are essential for hepatitis C virus (HCV) infection, but the underlying mechanism and relevance to other viruses or in vivo infections remained unknown.
|
28240606 |
2017 |
Parkinson Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
We describe recent advances on roles of kinases TAOK2, TNIK and CDKL5 in neuronal development and the converging pathways of LRRK2, PINK1 and GAK in Parkinson's Disease.
|
29241837 |
2018 |
Hepatitis C
|
0.040 |
Biomarker
|
disease |
BEFREE |
We demonstrated that the host kinases AAK1 and GAK regulate HCV infection by controlling these clathrin-associated APs.
|
29535204 |
2018 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |
High density lipoprotein measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |
Parkinsonian Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Although DNAJC6 (Auxilin), DNAJC12, and DNAJC5 (CSPα) exhibit strong genetic association with disease, DNAJC26 (GAK), DNAJC13 (RME-8), and DNAJC10 (Erdj5) require additional evidence to definitively link reported variants to parkinsonism.
|
31120186 |
2019 |
Parkinson Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Full sequencing of TMEM175/GAK/DGKQ followed by genotyping of specific associated variants was performed in PD (n = 1,575) and rapid eye movement sleep behavior disorder (RBD) patients (n = 533) and in controls (n = 1,583).
|
31658403 |
2020 |
REM Sleep Behavior Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Full sequencing of TMEM175/GAK/DGKQ followed by genotyping of specific associated variants was performed in PD (n = 1,575) and rapid eye movement sleep behavior disorder (RBD) patients (n = 533) and in controls (n = 1,583).
|
31658403 |
2020 |